GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

NCT04590547 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonitis
SARS-CoV Infection

Interventions

DRUG: GLS-1027
DRUG: Placebo

Sponsor

GeneOne Life Science, Inc.